|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����ɫ�� |
|
�������������� |
| ��������������� | |
|
������ |
|
Ƚ��ƽ |
|
�ܹ�ƽ |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
����ɫ����ҩ���о���״
������, Ƚ��ƽ, �ܹ�ƽ
�Ĵ���ѧ����ҽԺƤ���Բ���, �ɶ� 610041
��������ɫ���µķ�����Ľ���,�������ɫ���������ֵ�ҩ��������չ,���ָ������ֶԿ����ҩ��������Դ��ڲ���.Ŀǰ����ɫ����ҩ�����鷽����δ����.�����˽���������ѧ�߶�����ɫ�����·��෨���е�ҩ���о�.
[2] Guillot J, Gueho E. The diversity of Malassezia yeasts confirmed by rRNA sequence and nuclear DNA comparisons. Antonie Van Leeuwenhoek, 1995, 67(3):297-314.
[3] Nakamura Y, Kano R, Murai T, et al. Susceptibility testing of Malassezia species using the urea broth microdilution method. Antimicrob Agents Chemother, 2000, 44(8):2185-2186.
[4] Chryssanthou E, Broberger U, Petrini B. Malassezia pachydermatis fungaemia in a neonatal intensive care unit. Acta Paediatr, 2001,90(3):323-327.
[5] Gupta AK, Kohli Y, Li A, et al. In vitro susceptibility of the sevenMalassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br J Dermatol, 2000, 142(4):758-765.
[6] Palacin C, Tarrago C, Ortiz JA. In vitro activity of sertaconazole against Malassezia furfur and pachydermatis in different culture media.Methods Find Exp Clin Pharmacol, 1998, 20(6):451-455.
[7] Hammer KA, Carson CF, Riley TV. In vitro activities of ketoconazole, econazole, miconazole, and Melaleuca alternifolia(tea tree)oil against Malassezia species. Antimicrob Agents Chemother, 2000,44(2):467-469.
[8] Mickelsen PA, Viano-Paulson MC, Stevens DA, et al. Clinical and microbiological features of infection with Malassezia pachydermatis in high-risk infants. J Infect Dis, 1988, 157(6):1163-1168.
[9] Weseler A, Geiss HK, Saller R, et al. Antifungal effect of Australian tea tree oil on Malassezia pachydermatis isolated from canines suffering from cutaneous skin disease. Schweiz Arch Tierheilkd, 2002, 144(5):215-221.
[10] Murai T, Nakamura Y, Kano R, et al. Susceptibility testing of Malassezia pachydermatis using the urea broth microdilution method. Mycoses, 2002, 45(3-4):84-87.
[11] Leeming JP, Sansom JE, Burton JL. Susceptibility of Malassezia furfur subgroups to terbinafine. Br J Dermatol, 1997, 137(5):764-767.
[12] Nicholas BO, Berry V, Hunter PA, et al. The antifungal activity of mupirocin. J Antimicrob Chemother, 1999, 43(4):579-582.
[13] Tatsumi Y, Yokoo M, Arika T, et al. In vitro antifungal activity of KP103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs. Antimicrob Agents Chemother, 2001, 45(5):1493-1499.
[14] Uchida K, Nishiyama Y, Tanaka T, et al. In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species. Int J Antimicrob Agents, 2003, 21(3):234-238.
[15] Anaissie E, Paetznick V, Bodey GP. Fluconazole susceptibility testing of Candida albicans:microtiter method that is independent of inoculum size, temperature, and time of reading. Antimicrob Agents Chemother, 1991,35(8):1641-1646.
[16] Fromtling RA, Galgiani JN, Pfaller MA,et al. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother, 1993, 37(1):39-45.